A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tesofensine  | CAS 195875-84-4 - Request Quote

Picture of Tesofensine 

Tesofensine 

SZ CAT No:SZ-T175001
CAS No
195875-84-4
Mol.F.
C17H23Cl2NO
Mol.Wt.
328.3
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Tesofensine  is chemically (1R,2S,3S,5S)-3-(3,4-Dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane. Tesofensine  is supplied with detailed characterization data compliant with regulatory guideline. Tesofensine  can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tesofensine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 195875-84-4

Purchase 195875-84-4

Order 195875-84-4

Enquire 195875-84-4

price of 195875-84-4

195875-84-4 Supplier

195875-84-4 Manufacturer

195875-84-4 Exporter

buy high quality Tesofensine 

Purchase Tesofensine 

Tesofensine  suppliers

Tesofensine  manufacturers

Tesofensine  price

Order Tesofensine 

Enquire Tesofensine 

Tesofensine  cost

Tesofensine  Supplier

Tesofensine  Distributor

Tesofensine  for Method Validation

Tesofensine Reference Standard

Tesofensine  for ANDA Filing

Tesofensine  for Forced Degradation Studies

Tesofensine  Identification Standards

Tesofensine  for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,